NAIROBI, Kenya- For millions of women, getting a diagnosis for Endometriosis can take years — a delay that often prolongs pain, uncertainty, and, in many cases, worsening health.
The condition, in which tissue similar to the lining of the uterus grows outside it, affects an estimated 1 in 10 women of reproductive age globally.
Yet diagnosis remains notoriously slow, with patients frequently waiting between seven to ten years to receive confirmation.
Now, researchers and health technology companies say a wave of new diagnostic tools could dramatically shorten that timeline.
Traditionally, diagnosing Endometriosis has relied on invasive procedures such as laparoscopy, a surgical method that allows doctors to view tissue inside the abdomen. While effective, it is costly, time-consuming, and not always easily accessible.
Emerging technologies aim to change that. Among them are AI-powered imaging tools, advanced ultrasound techniques, and non-invasive blood or saliva-based tests designed to detect biomarkers linked to the disease.
Some startups are developing algorithms that analyse patient symptoms alongside imaging data to flag potential cases earlier, allowing clinicians to intervene sooner. Others are working on diagnostic kits that could one day be used in routine clinical settings — or even at home.
Early trials have shown promising results, with some technologies demonstrating the ability to identify signs of Endometriosis with significantly improved speed and accuracy compared to traditional pathways.
Experts say faster diagnosis could be transformative. Delays often mean prolonged suffering, repeated hospital visits, and increased risk of complications, including fertility challenges.
“Shortening the diagnostic journey is critical,” health specialists say, noting that earlier detection can improve treatment outcomes and quality of life.
However, researchers caution that many of these technologies are still in development and require further clinical validation before they become widely available.
Cost, accessibility, and integration into existing healthcare systems will also play a key role in determining their impact.
Patient advocacy groups have welcomed the innovation but stress that awareness among healthcare providers and the public remains equally important.
For now, the hope is clear: that advances in medical technology will finally close the gap between symptoms and diagnosis, offering millions of women quicker answers and better care.
